Health and Social Care – in the House of Commons at on 11 February 2025.
What discussions he has had with the Secretary of State for Foreign, Commonwealth and Development Affairs on the UK’s leadership on global health and immunisation.
UK leadership on global health is critical to safeguarding our national and international health security, building resilience and creating prosperity. I work closely with my counterparts across Government. I recently met the Foreign Secretary to discuss these issues, which are also high on the agenda of the Minister for Development. The UK has one of the largest vaccination programmes in the world, and our confidence and uptake rates are among the highest globally.
The NHS and the UK reap the benefits of our work in global health. Gavi is one of the UK’s greatest success stories: it has inoculated 1 billion children worldwide, but it has also strengthened our health security, keeping us safe from diseases such as Mpox and Ebola. What leadership will the Secretary of State and his Department take to strengthen organisations such as Gavi to keep us safe here in the UK?
The hon. Member raises an important point. I know that my ministerial colleagues in the Foreign, Commonwealth and Development Office are looking at the investment cases for Gavi and the Global Fund as part of the spending review. I will ensure that her representations are relayed to the FCDO, and she is very welcome to make those points during oral questions to that Department.
There were almost 67,000 cases of serious antimicrobial-resistant infections in the United Kingdom in 2023. War is increasing such infections globally; 80% of patients in one Kyiv hospital in Ukraine are said to have such infections. The Conservative Government had a plan to tackle that. Do the Labour Government plan to follow that plan, are they on track to meet those targets, and if not, what will the Secretary of State do about it?
I am delighted that Dame Sally Davies continues her work on antimicrobial resistance. That is an absolutely critical issue, and I pay tribute to the previous Government, particularly Minister Quince, for their work on it. It is in the national interest that we maintain not just the national focus but the international focus on antimicrobial resistance, which is why UK leadership in those global fora is so important.
Another time when it is important to work together is during a pandemic, such as by sharing research. Unfortunately, recent history tells us that when Labour negotiates, Britain loses out. Can the Secretary of State confirm that, whatever emerges from discussions with the World Health Organisation, he will not reduce the UK’s capacity to take decisions in the interests of the British people.